Abstract:Butyrate, a metabolite produced by gut bacteria, has demonstrated beneficial effects in the colon and has been used to treat inflammatory bowel diseases. However, the mechanism by which butyrate operates remains incompletely understood. Given that oral butyrate can exert either a direct impact on the gut mucosa or an indirect influence through its interaction with the gut microbiome, this study aimed to investigate three key aspects: (1) whether oral intake of butyrate modulates the expression of genes encoding short-chain fatty acid (SCFA) transporters ( Slc16a1 , Slc16a3 , Slc16a4 , Slc5a8 , Abcg2 ) and receptors ( Hcar2 , Ffar2 , Ffar3 , Olfr78 , Olfr558 ) in the colon, (2) the potential involvement of gut microbiota in this modulation, and (3) the impact of oral butyrate on the expression of colonic SCFA transporters and receptors during colonic inflammation. Specific pathogen-free (SPF) and germ-free (GF) mice with or without DSS-induced inflammation were provided with either water or a 0.5% sodium butyrate solution. The findings revealed that butyrate decreased the expression of Slc16a1 , Slc5a8 , and Hcar2 in SPF but not in GF mice, while it increased the expression of Slc16a3 in GF and the efflux pump Abcg2 in both GF and SPF animals. Moreover, the presence of microbiota was associated with the upregulation of Hcar2 , Ffar2, and Ffar3 expression and the downregulation of Slc16a3 . Interestingly, the challenge with DSS did not alter the expression of SCFA transporters, regardless of the presence or absence of microbiota, and the effect of butyrate on the transporter expression in SPF mice remained unaffected by DSS. The expression of SCFA receptors was only partially affected by DSS. Our results indicate that (1) consuming a relatively low concentration of butyrate can influence the expression of colonic SCFA transporters and receptors, with their expression being modulated by the gut microbiota, (2) the effect of butyrate does not appear to result from direct substrate-induced regulation but rather reflects an indirect effect associated with the gut microbiome, and (3) acute colon inflammation does not lead to significant changes in the transcriptional regulation of most SCFA transporters and receptors, with the effect of butyrate in the inflamed colon remaining intact.

Localization of a novel X-linked congenital stationary night blindness locus: close linkage to the RP3 type retinitis pigmentosa gene region.

Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

Contractile capacity of fibroblasts from different sources in the model of living skin equivalent

[In-vitro cancer cell growth regulation by fibroblasts, with special reference to the relationship with fibroblast aging].

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti.

Safe handling of vaccines.

Isolation of Cellulolytic Microfungi Involved in Wood-WasteDecomposition: Prospects for Enzymatic Hydrolysis ofCellulosic Wastes

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell

Microbial metabolite butyrate modulates granzyme B in tolerogenic IL-10 producing Th1 cells to regulate intestinal inflammation

Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation

, Dogs in Switzerland Canine Granulocytic Ehrlichia Infection in and of Ehrlichia canis Seroprevalence of

Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status

[Chemical constituents from Polygala telephioides].

Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells